NLS Pharmaceutics Ltd. (NASDAQ: NLSP) Featured in Coverage of the 35th Annual Roth Conference
NLS Pharmaceutics (NASDAQ: NLSP, NLSPW) is a global development-stage biopharmaceutical company, working with a network of world-class partners and internationally recognized scientists, focused on the discovery and development of innovative therapies for patients with rare and complex central nervous system, or CNS, disorders, who have unmet medical needs. Headquartered in Switzerland and founded in 2015, NLS is led by an experienced management team with a…